HomeNews

News

Nanolek Launches Russia’s First Full-Cycle Production of Human Papillomavirus (HPV) Vaccine

The biopharmaceutical company Nanolek, with the support of the Federal Industrial Development Fund (IDF), has launched the first domestic full-cycle production of a human...

Session “EAEU’s common market of medicinal products for veterinary use” at the All-Russian GMP Conference 2025

On September 15-17, 2025, the X All-Russian GMP Conference is being held in Moscow, organized by the Ministry of Industry and Trade of Russia...

Moscow Hosts the X GMP Conference Under the Motto “Regulating Today — Creating a Stable Tomorrow”

The business program of the X All-Russian GMP Conference with international participation covers a wide range of issues related to ensuring quality in the production of medicinal products, regulatory affairs, interagency and international cooperation in the pharmaceutical industry.

GMP-Inspections of veterinary manufacturers in the second quarter of 2025

The quarterly review provides information on the inspection of manufacturers of veterinary medicines for compliance with the requirements of the GMP which is carried out by specialists of the Inspection Body of the FSBI "VGNKI".

GEROPHARM and R-PHARM Pharmaceutical Plant in Azerbaijan Sign Partnership Agreement for Insulin Localisation

GEROPHARM and OOO “R-Pharm” (member of R-Pharm Group of Companies) have announced a strategic partnership to localise the production of medicines for the treatment of socially significant diseases in Azerbaijan.

Binnopharm Group has increased export production at its Zelenograd site by almost three times

In the first quarter of 2025, the Zelenograd production site of Binnopharm Group increased its output of medicinal products for export by almost three times compared to the same period in 2024.
spot_img

Expert Articles

spot_img